The historical rank and industry rank for GemPharmatech Co's OCF Margin % or its related term are showing as below:
SHSE:688046'
s OCF Margin % Range Over the Past 10 Years
Min: 13.15 Med: 28.7 Max: 81.47
Current: 30.06
During the past 8 years, the highest OCF Margin % of GemPharmatech Co was 81.47%. The lowest was 13.15%. And the median was 28.70%.
SHSE:688046's OCF Margin % is ranked better than 89.54% of 956
companies
in the Biotechnology industry
Industry Median: -68.59
vs SHSE:688046: 30.06
GemPharmatech Co OCF Margin % Related Terms
GemPharmatech Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for GemPharmatech Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688046 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, GemPharmatech Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GemPharmatech Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GemPharmatech Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where GemPharmatech Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GemPharmatech Co (SHSE:688046) has a OCF Margin % of -1.97% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GemPharmatech Co and its competitors. Over the past decade, GemPharmatech Co's OCF Margin % has ranged from 13.15 to 81.47. According to the industry distribution chart, GemPharmatech Co ranks #100 out of 956 companies in the Biotechnology industry, placing it in the top 10.5%.
Is GemPharmatech Co's OCF Margin % too high?
GemPharmatech Co's current OCF Margin % is -1.97%. Over the past 10 years, this metric has ranged from a low of 13.15 to a high of 81.47. Based on the distribution chart, GemPharmatech Co ranks #100 out of 956 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GemPharmatech Co has a GF Score™ of 95/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GemPharmatech Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GemPharmatech Co ranks #100 out of 956 companies for OCF Margin %. This places GemPharmatech Co in the top 11% of its industry — outperforming the majority of peers. Historically, GemPharmatech Co's own OCF Margin % has ranged from 13.15 to 81.47 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GemPharmatech Co and its competitors. GemPharmatech Co's current OCF Margin % is -1.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GemPharmatech Co stock overvalued right now?
Based on GuruFocus' analysis, GemPharmatech Co (SHSE:688046) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥19.42, compared to a current price of ¥25.77 — trading 32.7% above its estimated fair value. The current OCF Margin % is -1.97%. GemPharmatech Co's overall GF Score™ is 95/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For GemPharmatech Co (SHSE:688046), the current OCF Margin % is -1.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GemPharmatech Co (SHSE:688046) Overvalued in 2026?
Based on GuruFocus' analysis, GemPharmatech Co stock appears to be overvalued.
The current stock price of ¥25.77 is trading 32.7% above its estimated GF Value™ of ¥19.42.
GuruFocus considers GemPharmatech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688046:
OCF Margin %: -1.97%
GF Value™: ¥19.42 vs. price of ¥25.77 (32.7% above fair value)
No single metric tells the full story. See the SHSE:688046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.
95GF Score
Get the complete analysis for SHSE:688046
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688046 has been successfully added to your 
